Replies to post #102649 on Quantum Materials Corp. (fka QTMM)

[drugmanrx]

Supplying Pertinent Authenticated Material

SPAM-Hype Check is on full overload here!

Quantum Materials Corp. to Accelerate Development of QMC HealthID™ and Quantum Dot Research Following Equity Investment from
February 2, 2021, 6:40 AM EST

"work with Innova Medical Group Inc. and to expand the use of quantum dot technology to advance diagnostics in a broad range of disease states."

https://www.bloomberg.com/press-releases/2021-02-02/quantum-materials-corp-to-accelerate-development-of-qmc-healthid-and-quantum-dot-research-following-equity-investment-from

"On December 17, 2020, the Commission’s Division of Corporation Finance (“Corporation Finance”) sent a delinquency letter to QTMM requesting compliance with its periodic filing requirements, which was delivered.

https://www.sec.gov/litigation/suspensions/2021/34-91868-o.pdf

Does anyone believe that Pasaca Capital did not know about December 17, 2020 letter before signing the deal with QMC February 2, 2021 and naming them a portfolio company?

Does the new partnership with Neurolytixs indicate the Pasaca deal is still in progress to advance diagnostics in a broad range of disease states?

August 25, 2021
"We are currently developing 1) LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions), 2) a multiplex test that detects Covid-19, Flu and RSV (Respiratory Syncytial Virus), and 3) a vaccine validator (vac-check done) to thwart counterfeit vaccines and validate vaccine efficacy."

"In addition, the Company has signed a term sheet with a Canada-based biotech company that has identified (https://www.neurolytixs.com/about-us/announced partnership) and has a patent-pending on several( biomarker candidates that will be used to develop the TBI POCT. The term sheet is non-binding and we can provide no assurance that we will be able to reach definitive agreements on terms acceptable to the Company. We are in the process of negotiating the final terms that include the payment milestones required for QMC to design, develop, shepherd the FDA approval process, and produce the test kits."

https://www.neurolytixs.com/about-us/

Briana Zamora

I have stepped into the role of Senior Quality Assurance Analyst after a year as a production chemist. I am establishing a quality management system (QMS) in compliance with FDA quality system regulations and ISO 13485. Day to day, I work with a variety of teams implementing design controls, training, and communicating relevant regulations. I perform audits, reviews and investigations on medical devices in preparation for FDA submission.

August 25 they told us what they were going to do with vac-check and the Neurolytisis they appear they are following though, will that also be the care with the S-1.